Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons. [electronic resource]
Producer: 20180727Description: 1538-1548 p. digitalISSN:- 1939-327X
- Animals
- Appetite Depressants -- therapeutic use
- Diet, High-Fat -- adverse effects
- Energy Intake -- drug effects
- GABAergic Neurons -- drug effects
- Genes, Reporter -- drug effects
- Glucagon-Like Peptide-1 Receptor -- chemistry
- Green Fluorescent Proteins -- chemistry
- Hypoglycemic Agents -- therapeutic use
- Hypothalamus -- drug effects
- Liraglutide -- therapeutic use
- Male
- Mice, Knockout
- Mice, Transgenic
- Nerve Net -- drug effects
- Nerve Tissue Proteins -- agonists
- Neurons -- drug effects
- Obesity -- drug therapy
- Random Allocation
- Recombinant Fusion Proteins -- chemistry
- Vesicular Glutamate Transport Protein 2 -- chemistry
- Vesicular Inhibitory Amino Acid Transport Proteins -- chemistry
- Weight Loss -- drug effects
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.